BioCentury
ARTICLE | Clinical News

Viaskin Peanut: Phase III started

December 14, 2015 8:00 AM UTC

DBV began the double-blind, placebo-controlled, international Phase III PEPITES trial to evaluate 250 ug Viaskin Peanut for 12 months in about 330 patients ages 4-11. ...